This brand name is authorized in Japan, United States
The drug BELSOMRA contains one active pharmaceutical ingredient (API):
|
1
Suvorexant
UNII 081L192FO9 - SUVOREXANT
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05CJ01 | N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CJ Orexin receptor antagonists | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1190023F1024, 1190023F2020, 1190023F3027 |
| Country: US | FDA, National Drug Code | Identifier(s): 0006-0005, 0006-0033, 0006-0325, 0006-0335 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
